Feb 012023


From January 31 to February 1, the Federation Council of the Federal Assembly of the Russian Federation hosted the exhibition on Maternal and Child Health.

Almazov Centre exhibited the Tianox nitric oxide device intended for the production of nitric oxide from atmospheric air and inhaled nitric oxide therapy for various diseases in children and adults. The Centre successfully continues clinical trials of the device.

Almazov Centre also demonstrated a portable neonatal X-ray diagnostic system, which is successfully used by the doctors of the Centre. The system was jointly developed by scientists from Almazov Centre and St. Petersburg Electrotechnical University LETI. The system is composed of the Pardus-R portable microfocal X-ray device, a wireless X-ray detector and a mobile image processing unit with specialized software DiraX.5

Also, Almazov Centre presented its Smart Ward available in the Children's Rehabilitation Clinic (a joint project with the Shvabe holding). In a live broadcast, the process of using artificial intelligence was demonstrated, including patient monitoring, constant contact with doctors, connection of the medical information system and a remote medical consultation at the bedside.

During the exhibition, Almazov Centre presented research projects of the WCRC for Personalized Medicine in its main areas: population genetics and polygenic nature non-communicable diseases; unknown, rare and genetically determined diseases; oncology; infectious diseases, microbial and antimicrobial therapy.


As part of the event, Evgeny Shlyakhto, Director General of Almazov Centre, took part in the program on the Vmeste-RF TV channel and spoke about the experience of the Centre’s specialists in diagnosing and treating patients with hereditary, rare and understudied diseases.

The Children’s Rehabilitation Clinic provides treatment and testing for rare hereditary and orphan diseases such as genetically determined cardiomyopathies, rare variants of autoimmune diseases, congenital central hypoventilation syndrome (also referred to as Ondine's curse), Fabry disease, Pompe disease, hypophosphatasia, Moyamoya disease, methylmalonic acidemia, carnitine deficiency, cholesteryl ester storage disease, etc.



Уведомляем вас, что в соответствии с Федеральным законом от 06.03.2006 № 35-ФЗ «О противодействии терроризму» в Центре Алмазова введен комплекс дополнительных мер по безопасности, направленный на предотвращение террористических актов. В целях обеспечения безопасности граждан и целостности объектов инфраструктуры при посещении Центра Алмазова проводится дополнительный личный осмотр, осмотр вещей и автотранспорта. Отказ от соблюдения мер по безопасности может послужить причиной недопуска на территорию Центра Алмазова. Просим с пониманием отнестись к введенным мерам по безопасности.

С уважением, Администрация Центра Алмазова